Women’s Health Is Not a Women’s Issue. It’s an Economic Blind Spot

Women’s health economics does not usually enter boardroom discussions. It should. A recent argument by Maria Høyer Olsen made that clear, not through emotion, but through numbers that are hard to ignore.

We treat women’s health like a side topic. Meanwhile, the economic cost builds quietly in the background. Lost time. Delayed care. Reduced output.

Or maybe we see it. We just don’t call it what it is.


Women’s Health Economics: The Data Behind the Gender Health Gap

The numbers are not dramatic. That is precisely the problem.

  • Women wait 65 minutes longer in emergency rooms for the same pain
  • Women are 50 percent more likely to be misdiagnosed after a heart attack
  • Menstrual health issues cause up to 9 lost workdays per woman each year
  • Before 1993, women were largely excluded from clinical drug trials

According to the World Health Organization, gender gaps in diagnosis and treatment remain a persistent global issue.

Now bring this into a workplace context.

A company with 100 women could lose 900 workdays annually. Not because of inefficiency, but because systems were not designed with women’s health realities in mind.

Even more striking, research highlighted by McKinsey & Company shows that every $1 invested in women’s health can generate up to $3 in economic growth.

So this is not a social argument alone. It is an economic one.


The Design Problem in Women’s Health Economics

Still, the deeper issue sits in how systems were built.

Modern healthcare developed around male biology as the default reference point. Not always intentionally, but consistently enough to shape outcomes.

Symptoms differ. Pain signals vary. Drug responses are not identical.

However, protocols often remain unchanged.

That leads to predictable consequences:

  • Delayed recognition of symptoms
  • Higher rates of misdiagnosis
  • Treatments that are less effective than they should be

This is not about individual failure. It is about system design.

And system design, once established, rarely corrects itself without pressure.


Workplace Productivity Loss in Women’s Health Economics

Let’s bring this closer to reality.

In Karachi, offices run on targets, deadlines, and performance reviews. Every metric is tracked carefully.

Except this one.

An employee dealing with untreated menstrual pain or a misdiagnosed condition still comes to work. She completes tasks. She attends meetings. From the outside, everything looks normal.

In reality, productivity drops quietly.

Multiply that across teams and months.

The impact becomes visible, not in one report, but in patterns. Slower execution. Missed timelines. Fatigue that builds without explanation.

At the same time, companies invest heavily in automation, analytics, and marginal efficiency gains. Yet something as basic as women’s health economics remains under-addressed.

Maybe it feels complex. Or perhaps it has simply not been framed as a measurable business issue.


Why Women’s Health Economics Is Not About Sympathy

This is where the argument shifts.

Women’s health economics is not about sympathy or special treatment. It is about correcting inefficiencies that affect entire systems.

Better health outcomes lead to:

  • stronger workforce participation
  • improved productivity
  • more stable households
  • reduced long-term healthcare costs

Men benefit as well. Relationships improve. Family stress reduces. Workplace balance becomes easier to sustain.

So the impact is shared.


The Cost of Ignoring Women’s Health Economics

The most important point is also the simplest.

We are already paying the cost.

  • In delayed diagnoses
  • In lost productivity
  • In preventable complications
  • In economic inefficiency

In Pakistan, where workplace health policies are still evolving, this gap is likely even wider, though rarely measured or formally acknowledged.

Once you begin to see it, it becomes difficult to ignore.


Conclusion

Women’s health economics requires a shift in thinking. From fairness to function. From awareness to measurable action.

Ignore it, and the losses continue quietly. Address it, and the benefits spread across companies, families, and entire economies.

The data has been available for years.

We just have not been honest about what it means.


AI transparency: This article was written by a human, refined with AI assistance for clarity and structure